The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ELCC 2017 | Exciting current topics in lung cancer

Name: Exciting current topics in lung cancer
Uploaded: 2017-05-05T00:00:00.000Z
Duration: 1 min 33 s
Description: Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the conference highlights at the annual meeting of European Lung Cancer Conference (ELCC) 2017 in Geneva, Switzerland. Dr Peters describes three points that she found particularly interesting; managing toxicities, combination immunotherapy, and using immunotherapy in PDL1 negative patients.

Solange Peters • 5 May 2017

ELCC 2017

Lung Cancer

Solange Peters, MD, PhD from the University of Lausanne, Lausanne, Switzerland discusses the conference highlights at the annual meeting of European Lung Cancer Conference (ELCC) 2017 in Geneva, Switzerland. Dr Peters describes three points that she found particularly interesting; managing toxicities, combination immunotherapy, and using immunotherapy in PDL1 negative patients.